HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pramila Bhatia Selected Research

Erectile Dysfunction

8/20061-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction.
4/2006Dopamine D4 receptor signaling in the rat paraventricular hypothalamic nucleus: Evidence of natural coupling involving immediate early gene induction and mitogen activated protein kinase phosphorylation.
7/2004Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pramila Bhatia Research Topics

Disease

3Pain (Aches)
02/2012 - 11/2005
3Erectile Dysfunction
08/2006 - 07/2004
2Hyperalgesia
02/2012 - 02/2012
1Chronic Pain
02/2012
1Hypersensitivity (Allergy)
02/2012
1Neuralgia (Stump Neuralgia)
09/2006
1Schizophrenia (Dementia Praecox)
04/2006

Drug/Important Bio-Agent (IBA)

2Capsaicin (Zostrix)FDA Link
02/2012 - 02/2012
2metabotropic glutamate receptor type 1IBA
09/2006 - 11/2005
2Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
08/2006 - 04/2006
1A-1048400IBA
02/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
02/2012
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
09/2006
1OximesIBA
08/2006
1Dopamine Agents (Dopaminergic Agents)IBA
07/2004

Therapy/Procedure

1Oral Administration
02/2012